Clinical Trials in Carlton, Australia
2 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Bristol-Myers Squibb3,040 enrolled351 locationsNCT07116967
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Bristol-Myers Squibb586 enrolled106 locationsNCT06976216
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Phase 3
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Eli Lilly and Company1,000 enrolled186 locationsNCT07412756
Recruiting
Phase 3
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Neurocrine Biosciences550 enrolled45 locationsNCT07196501
Recruiting
Phase 3
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)
Incyte Corporation600 enrolled330 locationsNCT06855498
Recruiting
Phase 3
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
PTSD - Post Traumatic Stress Disorder
Senseye, Inc.1,900 enrolled6 locationsNCT07280065
Recruiting
Not Applicable
An Evaluation of the Safety and Tolerability of Ocular Lubricants
Alcon Research148 enrolled4 locationsNCT07238699
Recruiting
Phase 2
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Takeda90 enrolled49 locationsNCT07244263
Recruiting
Phase 3
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
Hidradenitis Suppurativa
AbbVie1,328 enrolled285 locationsNCT05889182
Recruiting
Phase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
AbbVie1,500 enrolled267 locationsNCT06012240
Recruiting
Phase 2
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Treatment Resistant Depression
atai Therapeutics, Inc.142 enrolled42 locationsNCT06524830
Recruiting
Phase 3
Silexan in the Treatment Of Posttraumatic Stress Disorder Trial
Post Traumatic Stress Disorder
Deakin University278 enrolled4 locationsNCT06412757
Recruiting
Phase 2
Efficacy and Safety of HB-1 for Panic Disorder
Panic DisorderMental Illness
Honeybrains Biotech LLC240 enrolled22 locationsNCT06483789
Recruiting
Phase 1Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Sanofi Pasteur, a Sanofi Company260 enrolled93 locationsNCT06316297
Recruiting
Phase 3
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Vitiligo
Pfizer400 enrolled74 locationsNCT06163326
Recruiting
Not Applicable
Dose-Response Effects of Mindfulness Meditation
DepressionWell-Being, Psychological
University of Melbourne860 enrolled1 locationNCT06378450
Recruiting
Phase 2
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis
Plaque Psoriasis
Zai Lab (Hong Kong), Ltd.250 enrolled10 locationsNCT06380907